Literature DB >> 22429651

Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes.

Theodore A Omachi1, Paul D Blanc, David M Claman, Hubert Chen, Edward H Yelin, Laura Julian, Patricia P Katz.   

Abstract

OBJECTIVE: To investigate the cross-sectional association between COPD severity and disturbed sleep and the longitudinal association between disturbed sleep and poor health outcomes.
METHODS: Ninety eight adults with spirometrically-confirmed COPD were recruited through population-based, random-digit telephone dialing. Sleep disturbance was evaluated using a 4-item scale assessing insomnia symptoms as: difficulty falling asleep, nocturnal awakening, morning tiredness, and sleep duration adequacy. COPD severity was quantified by: FEV(1) and COPD Severity Score, which incorporates COPD symptoms, requirement for COPD medications and oxygen, and hospital-based utilization. Subjects were assessed one year after baseline to determine longitudinal COPD exacerbations and emergency utilization and were followed for a median 2.4 years to assess all-cause mortality.
RESULTS: Sleep disturbance was cross-sectionally associated with cough, dyspnea, and COPD Severity Score, but not FEV(1). In multivariable logistic regression, controlling for sociodemographics and body-mass index, sleep disturbance longitudinally predicted both incident COPD exacerbations (OR=4.7; p=0.018) and respiratory-related emergency utilization (OR=11.5; p=0.004). In Cox proportional hazards analysis, controlling for the same covariates, sleep disturbance predicted poorer survival (HR=5.0; p=0.013). For all outcomes, these relationships persisted after also controlling for baseline FEV(1) and COPD Severity Score.
CONCLUSIONS: Disturbed sleep is cross-sectionally associated with worse COPD and is longitudinally predictive of COPD exacerbations, emergency health care utilization, and mortality.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22429651      PMCID: PMC3336048          DOI: 10.1016/j.sleep.2011.12.007

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  46 in total

1.  Missing data: our view of the state of the art.

Authors:  Joseph L Schafer; John W Graham
Journal:  Psychol Methods       Date:  2002-06

2.  Measurement of COPD severity using a survey-based score: validation in a clinically and physiologically characterized cohort.

Authors:  Mark D Eisner; Theodore A Omachi; Patricia P Katz; Edward H Yelin; Carlos Iribarren; Paul D Blanc
Journal:  Chest       Date:  2009-12-29       Impact factor: 9.410

Review 3.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

4.  Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population.

Authors:  A Mykletun; E Stordal; A A Dahl
Journal:  Br J Psychiatry       Date:  2001-12       Impact factor: 9.319

5.  Effect of pulmonary rehabilitation on quality of life in patients with COPD: the use of SF-36 summary scores as outcomes measures.

Authors:  R Benzo; P A Flume; D Turner; M Tempest
Journal:  J Cardiopulm Rehabil       Date:  2000 Jul-Aug       Impact factor: 2.081

6.  Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill.

Authors:  M Manocchia; S Keller; J E Ware
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

7.  Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study.

Authors:  Vincenzo Bellia; Filippo Catalano; Nicola Scichilone; Raffaele Antonelli Incalzi; Mario Spatafora; Carlo Vergani; Franco Rengo
Journal:  Sleep       Date:  2003-05-01       Impact factor: 5.849

8.  The accuracy of self-reported healthcare resource utilization in health economic studies.

Authors:  Stavros Petrou; Lynne Murray; Peter Cooper; Leslie L Davidson
Journal:  Int J Technol Assess Health Care       Date:  2002       Impact factor: 2.188

Review 9.  COPD exacerbations: definitions and classifications.

Authors:  S Burge; J A Wedzicha
Journal:  Eur Respir J Suppl       Date:  2003-06

10.  Patient-reported use of health service resources compared with information from health providers.

Authors:  Suzanne H Richards; Joanna Coast; Tim J Peters
Journal:  Health Soc Care Community       Date:  2003-11
View more
  56 in total

1.  Prescription Synthetic Oral Cannabinoid use Among Older Adults with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.

Authors:  Nicholas T Vozoris; Zhan Yao; Ping Li; Peter C Austin; Anne L Stephenson; Sudeep S Gill; Denis E O'Donnell; Andrea S Gershon; Paula A Rochon
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

2.  Sex and age differences in the associations between sleep behaviors and all-cause mortality in older adults: results from the National Health and Nutrition Examination Surveys.

Authors:  Hind A Beydoun; May A Beydoun; Xiaoli Chen; Jen Jen Chang; Alyssa A Gamaldo; Shaker M Eid; Alan B Zonderman
Journal:  Sleep Med       Date:  2017-05-29       Impact factor: 3.492

3.  Sleep Disturbance in Smokers with Preserved Pulmonary Function and with Chronic Obstructive Pulmonary Disease.

Authors:  Lucas M Donovan; Peter J Rise; Shannon S Carson; Laura C Feemster; Matthew F Griffith; Vishesh K Kapur; Jerry A Krishnan; Peter K Lindenauer; Richard A Mularski; Edward T Naureckas; Brian N Palen; Elizabeth C Parsons; Laura J Spece; Michael V Vitiello; David H Au
Journal:  Ann Am Thorac Soc       Date:  2017-12

4.  Sleep Quality and Nocturnal Symptoms in a Community-Based COPD Cohort.

Authors:  Aditi Shah; Najib Ayas; Wan-Cheng Tan; Atul Malhotra; John Kimoff; Marta Kaminska; Shawn D Aaron; Rachel Jen
Journal:  COPD       Date:  2020-01-10       Impact factor: 2.409

5.  Sleep Moderates and Mediates the Relationship Between Acculturation and Depressive Symptoms in Pregnant Mexican-American Women.

Authors:  Kimberly L D'Anna-Hernandez; Esmeralda Garcia; Mary Coussons-Read; Mark L Laudenslager; Randal G Ross
Journal:  Matern Child Health J       Date:  2016-02

6.  Sleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS).

Authors:  Michelle R Zeidler; Jennifer L Martin; Eric C Kleerup; Hartmut Schneider; Michael N Mitchell; Nadia N Hansel; Krishna Sundar; Helena Schotland; Robert C Basner; J Michael Wells; Jerry A Krishnan; Gerard J Criner; Stephanie Cristenson; Samuel Krachman; M Safwan Badr
Journal:  Sleep       Date:  2018-05-01       Impact factor: 5.849

7.  Tiotropium Respimat Soft Mist Inhaler versus HandiHaler to improve sleeping oxygen saturation and sleep quality in COPD.

Authors:  Izolde Bouloukaki; Nikolaos Tzanakis; Charalampos Mermigkis; Katerina Giannadaki; Violeta Moniaki; Eleni Mauroudi; Stylianos Michelakis; Sophia E Schiza
Journal:  Sleep Breath       Date:  2015-09-25       Impact factor: 2.816

Review 8.  Sleep disorders in chronic obstructive pulmonary disease: etiology, impact, and management.

Authors:  Rohit Budhiraja; Tauseef A Siddiqi; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

9.  Retrospective Assessment of Home Ventilation to Reduce Rehospitalization in Chronic Obstructive Pulmonary Disease.

Authors:  Steven Coughlin; Wei E Liang; Sairam Parthasarathy
Journal:  J Clin Sleep Med       Date:  2015-06-15       Impact factor: 4.062

10.  Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors.

Authors:  Karen M Mustian; Lisa K Sprod; Michelle Janelsins; Luke J Peppone; Oxana G Palesh; Kavita Chandwani; Pavan S Reddy; Marianne K Melnik; Charles Heckler; Gary R Morrow
Journal:  J Clin Oncol       Date:  2013-08-12       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.